在研3款AD药物,20年无所出,罗氏再掷30亿美元欲抢占时机?
https://www.pmlive.com/pharma_news/roche_engaged_in_talks_with_fda_for_alzheimers_drug_candidate_1373506
http://www.rrrry.com/art_54663.htm
https://www.morphosys.com/media-investors/media-center/morphosys-and-roche-collaborate-on-alzheimers-disease
https://www.technologynetworks.com/neuroscience/blog/a-vaccine-for-alzheimers-disease-an-interview-with-ac-immunes-prof-andrea-pfeifer-343214
https://www.alzforum.org/therapeutics/gantenerumab
https://alzheimersnewstoday.com/2021/06/28/gantenerumab-lowers-key-protein-levels-in-early-onset-disease-trial/
https://www.genengnews.com/news/genentechs-crenezumab-fails-two-phase-iii-trials-in-alzheimers/
https://www.pharmaceutical-technology.com/comment/roche-crenezumab-2019/
https://synthetic.com/this-startup-targets-transfer-rna-trna-mechanism/